SOLICITATION NOTICE
A -- Clinical Coordinating Center for NIDA Clinical Trials Network
- Notice Date
- 10/28/2004
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6101 Executive Boulevard, Bethesda, MD, 20892
- ZIP Code
- 20892
- Solicitation Number
- N01DA-5-2208
- Response Due
- 1/11/2005
- Point of Contact
- Diane Loeb, Contract Specialist, NIDA/NIH, Phone 301 443-6677, Fax 301 443-7595, - Nancy Hurd, Contracting Officer, Phone (301) 443-6677, Fax (301) 443-7595,
- E-Mail Address
-
dloeb@nida.nih.gov, nh31d@nih.gov
- Small Business Set-Aside
- Total Small Business
- Description
- THIS REQUIREMENT IS A 100% TOTAL SMALL BUSINESS SET-ASIDE. The North American Industrial Classification System (NAICS) code identified for this requirement is 541710 with a size standard of 500 employees. The National Institute on Drug Abuse (NIDA) is soliciting proposals from small business concerns to provide resources to support for multiple and simultaneously-running multi-site clinical trials conducted under the National Institute on Drug Abuse Center for the Clinical Trials Network (CCTN). The development of the CCTN was based, in part, upon a recommendation from the National Advisory Council on Drug Abuse and conclusions of the Physicians Leadership on National Drug Policy. The Institute of Medicine/National Academy of Sciences report "Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment" also recommended a national network for drug abuse treatment trials. Following the first NIDA CTN solicitation in 1999, six CTN awards were made to awardees in California, Connecticut, New York, Oregon, Maryland, and Pennsylvania. After a solicitation in 2000, awards were subsequently made to five additional sites in Colorado, Florida, Michigan, Ohio, and South Carolina. In 2001 three additional sites were awarded in New York (Long Island), North Carolina and Washington. In 2002 there were three additional sites added in California, Massachusetts, and New Mexico. These sites represent a variety of treatment traditions that include pharmacological as well as behavioral and other psychosocial interventions. Furthermore, NIDA ensured a wide variety of patient populations in the selection of CTN recipients. Women, minority groups, and adolescents are well represented. A new RFA DA-05-001 was released July 7, 2004, to fund eleven new and/or competing applications to replace the first eleven Nodes that are expiring in August 2005. The location of the Nodes and their Community Treatment Providers may change depending on the awards given out for this RFA. The purpose of this contract is to provide a wide range of clinical trial administrative support and related services for multi-site clinical trials conducted within the NIDA Clinical Trials Network (CTN). No actual clinical trials will be carried out under this contract. Activities under this contract will support the trials carried out under cooperative agreements (U-10) with Regional Research and Training Centers (RRTC) located across the nation. The work required under this contract includes: 1) Providing support for regulatory functions and requirements; 2) Reviewing and monitoring protocol implementation; 3) Providing training to research staff; 4) Providing pharmaceutical services and clinical support; 5) Providing drug testing and analytical laboratory services; 6) Providing support for protocol development in the areas related to the tasks specified in the Statement of Work; 7) Participating in relevant committee and subcommittee meetings and conference calls; and, 8) Providing other expert consultation and support services as needed. This will be a three-year contract with options to extend for two additional years plus options to cover an increase in the number of RRTCs in the network. RFP No. NO1DA-5-2208 will be available electronically on or about November 12, 2004, and may be accessed through the NIDA website at the following address: (URL: http://www.nida.nih.gov/RFP/RFPList.html). Please note that the RFP for this acquisition will be streamlined to include only the Work Statement, Deliverables, Reporting Requirements, Special Requirements, Mandatory Qualifications, Technical Evaluation Criteria, and other necessary Proposal Preparation Instructions. However, all information required for the submission of an offer will be contained in or accessible through the streamlined electronic RFP package. Response to the RFP is due on or about January 11, 2005. This advertisement does not commit the Government to award a contract. See numbered note 26. NOTE: THIS NOTICE WAS NOT POSTED TO WWW.FEDBIZOPPS.GOV ON THE DATE INDICATED IN THE NOTICE ITSELF (28-OCT-2004); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link to FedBizOpps document.
(http://www.eps.gov/spg/HHS/NIH/NIDA-01/N01DA-5-2208/listing.html)
- Record
- SN00700394-F 20041030/041028212312 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |